A Guide to Due Diligence in Life Science Transactions

Drug and Market Development Publishing
September 1, 2002
75 Pages - SKU: DSMD827191
License type:
Countries covered: Global

A Guide to Due Diligence in Life Science Transactions

 
D&MD's Guide to Due Diligence provides an essential introduction to due diligence for readers, including a summary of key investigation areas and critical questions to ask, as well as checklists readily employable in day-to-day business operations. Most importantly, this Guide focuses on the life sciences, and unique business issues within this industry that are not covered in any other comparable publication.



Additional Information

This is the only Guide specifically tailored to provide a thorough introduction and overview of the due diligence process for life science ventures.

In the life science industry, buyers and sellers can take several forms. A seller can be a company seeking a merger or acquisition, divesting a product line, licensing a technology, promoting an IPO, or an entrepreneur seeking venture investment. Buyers are the groups looking to acquire, invest, or otherwise purchase from the seller. In any given business transaction the seller will seek to achieve the highest price for their goods, and as a result has an incentive to "polish" any blemishes that would reduce the value for their goods or preclude the transaction from occurring. It is the responsibility of the buyer to uncover these blemishes, and determine how that affects the deal. Due diligence is the response to the cliché "Let the Buyer Beware."

D&MD's Guide to Due Diligence provides an essential introduction to due diligence for readers, including a summary of key investigation areas and critical questions to ask, as well as checklists readily employable in day-to-day business operations. Most importantly, this Guide focuses on the life sciences, and unique business issues within this industry that are not covered in any other comparable publication.

More Global Regulation & Policy Reports

Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition by Kalorama Information
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, ...

Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on Europe by BCC Research
REPORT HIGHLIGHTS The global pharmaceutical contract manufacturing and contract research organizations revenue reached at $196.5 billion in 2010, it will further grow to $217.9 billion ...

Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets by BCC Research
The global pharmaceutical contract manufacturing and contract research organizations revenue reached at $196.5 billion in 2010, it will further grow to $217.9 billion in 2011 ...

The World Pharmaceutical Markets Fact Book 2011 by Espicom Healthcare Intelligence
The indispensable source of thousands of facts, figures and statistics for 66 pharmaceutical markets worldwide! In today's challenging market environment the need to understand ...

Global Markets for Orphan Drugs by BCC Research
THIS REPORT CONTAINS An overview of orphan drug criteria, the history of the Orphan Drug Act and its influence and advantages inherent in ...

See all reports like this >>